Dr. Peter Ang Cher Siang

Medical Oncology (Cancer)

Credentials	MBBS (Singapore) M.Med (Singapore) MRCP (United Kingdom) FAMS (Medical Oncology)
Language	English,Mandarin Chinese,Hokkien Dialect,Cantonese Dialect,Teochew Dialect
Background	Dr Peter Ang graduated from the National University of Singapore in 1991. He obtained his Master of Medicine (Internal Medicine) and Membership of the Royal College of Physician (United Kingdom) in 1997. In 2000, he was awarded the Ministry of Health Manpower Development Programme (HMDP) Scholarship to train at Dana Farber Cancer Institute, (Teaching Affiliates of Harvard Medical School), Boston USA. His training was in general oncology with a particular focus on breast cancer and cancer genetics. He had also qualified with the European Society of Medical Oncology (ESMO) certifying exam for medical oncologists topping the examination by being second in score for year 2000. In 2001, he was one of the first to qualify with the Familial Cancer Risk Assessment and Management Exam certification by Institute of Clinical Evaluation for the practice of cancer genetics. Prior to entering private practice, he was Senior Consultant Medical Oncologist and Director of the Cancer Education Service (2004) at the National Cancer Centre, Singapore. He was also a visiting consultant to KK Hospital. He was the leading oncologist of the Breast Cancer Workgroup (2002) for National Cancer Centre and Singhealth cluster and was involved in the cluster Breast Cancer Health Management Plan (2003). He was program leader for the Public Cancer Education with Singhealth Cancer Service Development Line (2004). In clinical work, he was awarded the National Excellent Service Award (EXSA) in 2005. He has been actively involved in clinical and translational research for many years, in breast and other cancers. These have involved international trials of chemotherapy drugs currently in active use and newer targeted therapy drugs such as herceptin, lapatinib and sunitinib. He was principal investigator for more than 10 clinical trials. Research work by Dr Ang has been published in both local and international journals including Journal of Clinical Oncology, Chest, Lancet Oncology, Seminars in Oncology, Cancer Epidemiology Biomarker & Prevention, Clinical Cancer Research, Clinical Genetics, Pharmacogenomics and Respiratory Medicine. He was also the editor and main author of a book on breast cancer, “Illustrative Cases in Breast Cancer” (2006). He has also been a reviewer for several medical journals, including American Journal of Clinical Oncology, World Journal of Surgical Oncology, Annals of Academy of Medicine Singapore and Oncology journal. Dr Ang is currently a Visiting Consultant to National Cancer Centre and is actively involved in research and teaching. He had been an active clinical teacher with the National University of Singapore and had been a speaker for Breast Cancer Foundation and Singapore Cancer Society. He had been one of the speakers for the first Singapore Medical Oncology Review Course (2007) and the first regional Asian Oncology Summit, 2009.
Achievements	Graduated from the National University of Singapore in 1991 •Obtained Master of Medicine (Internal Medicine) and Membership of the Royal College of Physicians (United Kingdom) in 1997 •Awarded the Ministry of Health Manpower Development Programme (HMDP) Scholarship to train at Dana Farber Cancer Institute, (Teaching Affiliates of Harvard Medical School), Boston USA 2000-2001. •He was the leading oncologist of the Breast Cancer Workgroup (2002) for National Cancer Centre and Singhealth cluster and was involved in the cluster Breast Cancer Health Management Plan (2003). He was program leader for the Public Cancer Education with Singhealth Cancer Service Development Line (2004). •In clinical patient care, he was awarded the National Excellent Service Award (EXSA) in 2005 •.Established the Cancer Genetics Service in National Cancer Centre and pioneered the first comprehensive study of cancer genetic testing for BRCA1 and BRCA2 genes in an Asian population. In 2003, he was commissioned to write a paper for the National Bioethics Advisory Committee as part of the framework to develop ethical, legal and social issues in genetic testing. •He has been actively involved in clinical and translational research for many years, in breast and other cancers. These have involved international trials of chemotherapy drugs currently in active use and newer targeted therapy drugs such as herceptin, lapatinib and sunitinib. He was principal investigator for more than 10 clinical trials for cancer drug development. •Research work by Dr Ang has been published in both local and international journals including Journal of Clinical Oncology, Chest, Lancet Oncology, Seminars in Oncology, Cancer Epidemiology Biomarker & Prevention, Clinical Cancer Research, Clinical Genetics, Pharmacogenomics and Respiratory Medicine. He was also the editor and main author of a book on breast cancer, “Illustrative Cases in Breast Cancer” (2006). He has also been a reviewer for several medical journals, including American Journal of Clinical Oncology, World Journal of Surgical Oncology, Annals of Academy of Medicine Singapore and Oncology journal. •With respect to public service, he has National Breast Cancer Awareness Month 2005 co-chairman, involving the Singhealth and NHG cluster hospitals, Breast Cancer Foundation and Singapore Cancer Society. He has conducted lectures for University undergraduates, postgraduate doctors training in medical oncology, training nurses and public forums by the Breast Cancer Foundation and the Singapore Cancer Society. He had been one of the speakers for the first Singapore Medical Oncology Review Course (2007) and the first regional Asian Oncology Summit, 2009 involving local and regional oncology doctors •.Accredited for Palliative Medicine

Credentials

MBBS (Singapore) M.Med (Singapore) MRCP (United Kingdom) FAMS (Medical Oncology)

Language

English,Mandarin Chinese,Hokkien Dialect,Cantonese Dialect,Teochew Dialect

Background

Dr Peter Ang graduated from the National University of Singapore in 1991. He obtained his Master of Medicine (Internal Medicine) and Membership of the Royal College of Physician (United Kingdom) in 1997. In 2000, he was awarded the Ministry of Health Manpower Development Programme (HMDP) Scholarship to train at Dana Farber Cancer Institute, (Teaching Affiliates of Harvard Medical School), Boston USA. His training was in general oncology with a particular focus on breast cancer and cancer genetics. He had also qualified with the European Society of Medical Oncology (ESMO) certifying exam for medical oncologists topping the examination by being second in score for year 2000. In 2001, he was one of the first to qualify with the Familial Cancer Risk Assessment and Management Exam certification by Institute of Clinical Evaluation for the practice of cancer genetics.

Prior to entering private practice, he was Senior Consultant Medical Oncologist and Director of the Cancer Education Service (2004) at the National Cancer Centre, Singapore. He was also a visiting consultant to KK Hospital. He was the leading oncologist of the Breast Cancer Workgroup (2002) for National Cancer Centre and Singhealth cluster and was involved in the cluster Breast Cancer Health Management Plan (2003). He was program leader for the Public Cancer Education with Singhealth Cancer Service Development Line (2004). In clinical work, he was awarded the National Excellent Service Award (EXSA) in 2005.

He has been actively involved in clinical and translational research for many years, in breast and other cancers. These have involved international trials of chemotherapy drugs currently in active use and newer targeted therapy drugs such as herceptin, lapatinib and sunitinib. He was principal investigator for more than 10 clinical trials. Research work by Dr Ang has been published in both local and international journals including Journal of Clinical Oncology, Chest, Lancet Oncology, Seminars in Oncology, Cancer Epidemiology Biomarker & Prevention, Clinical Cancer Research, Clinical Genetics, Pharmacogenomics and Respiratory Medicine. He was also the editor and main author of a book on breast cancer, “Illustrative Cases in Breast Cancer” (2006). He has also been a reviewer for several medical journals, including American Journal of Clinical Oncology, World Journal of Surgical Oncology, Annals of Academy of Medicine Singapore and Oncology journal.

Dr Ang is currently a Visiting Consultant to National Cancer Centre and is actively involved in research and teaching. He had been an active clinical teacher with the National University of Singapore and had been a speaker for Breast Cancer Foundation and Singapore Cancer Society. He had been one of the speakers for the first Singapore Medical Oncology Review Course (2007) and the first regional Asian Oncology Summit, 2009.

Achievements

Graduated from the National University of Singapore in 1991

•Obtained Master of Medicine (Internal Medicine) and Membership of the Royal College of Physicians (United Kingdom) in 1997

•Awarded the Ministry of Health Manpower Development Programme (HMDP) Scholarship to train at Dana Farber Cancer Institute, (Teaching Affiliates of Harvard Medical School), Boston USA 2000-2001.

•He was the leading oncologist of the Breast Cancer Workgroup (2002) for National Cancer Centre and Singhealth cluster and was involved in the cluster Breast Cancer Health Management Plan (2003). He was program leader for the Public Cancer Education with Singhealth Cancer Service Development Line (2004).

•In clinical patient care, he was awarded the National Excellent Service Award (EXSA) in 2005

•.Established the Cancer Genetics Service in National Cancer Centre and pioneered the first comprehensive study of cancer genetic testing for BRCA1 and BRCA2 genes in an Asian population. In 2003, he was commissioned to write a paper for the National Bioethics Advisory Committee as part of the framework to develop ethical, legal and social issues in genetic testing.

•He has been actively involved in clinical and translational research for many years, in breast and other cancers. These have involved international trials of chemotherapy drugs currently in active use and newer targeted therapy drugs such as herceptin, lapatinib and sunitinib. He was principal investigator for more than 10 clinical trials for cancer drug development.

•Research work by Dr Ang has been published in both local and international journals including Journal of Clinical Oncology, Chest, Lancet Oncology, Seminars in Oncology, Cancer Epidemiology Biomarker & Prevention, Clinical Cancer Research, Clinical Genetics, Pharmacogenomics and Respiratory Medicine. He was also the editor and main author of a book on breast cancer, “Illustrative Cases in Breast Cancer” (2006). He has also been a reviewer for several medical journals, including American Journal of Clinical Oncology, World Journal of Surgical Oncology, Annals of Academy of Medicine Singapore and Oncology journal.

•With respect to public service, he has National Breast Cancer Awareness Month 2005 co-chairman, involving the Singhealth and NHG cluster hospitals, Breast Cancer Foundation and Singapore Cancer Society. He has conducted lectures for University undergraduates, postgraduate doctors training in medical oncology, training nurses and public forums by the Breast Cancer Foundation and the Singapore Cancer Society. He had been one of the speakers for the first Singapore Medical Oncology Review Course (2007) and the first regional Asian Oncology Summit, 2009 involving local and regional oncology doctors

•.Accredited for Palliative Medicine